4.7 Article

GDE7 produces cyclic phosphatidic acid in the ER lumen functioning as a lysophospholipid mediator

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Hypoxia increases cellular levels of phosphatidic acid and lysophospholipids in undifferentiated Caco-2 cells

Yoshibumi Shimizu et al.

Summary: This study found that Caco-2 cells derived from human colon cancer have increased levels of phosphatidic acid and its lysoform, lysophosphatidic acid (LPA), under hypoxic conditions. The elevation of LPA in Caco-2 cells is mainly due to the increased levels of lysophosphatidylcholine and lysophosphatidylethanolamine, which are hydrolyzed by phospholipase A(2) and lysophospholipase D.

LIPIDS (2023)

Article Biochemical Research Methods

Development and validation of a simple and rapid HILIC-MS/MS method for the quantification of low-abundant lysoglycerophospholipids in human plasma

Haonan Li et al.

Summary: This study developed and validated a simple and rapid LC-MS/MS method for the quantification of low-abundance lysoglycerophospholipids (Lyso-GPLs) in plasma. The method showed good accuracy and sensitivity, and enabled the quantification of different types of Lyso-GPLs. The application of this method can improve understanding of the roles of circulating low-abundant Lyso-GPLs in health and diseases.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2023)

Review Pathology

Lysophospholipid Mediators in Health and Disease

Kuniyuki Kano et al.

Summary: Lysophospholipids, such as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are important extracellular lipid mediators that signal through specific G protein-coupled receptors. They play crucial roles in various biological processes and diseases, including cellular stress signaling, inflammation, and host defense responses. LPA is involved in regulating fibrosis, neuropathic pain, abnormal angiogenesis, endometriosis, and neuroectodermal developmental disorders, while S1P controls collective behavior, apoptotic cell clearance, and immunesurveillance of cancers. The study of lysophospholipids has led to the development of new therapeutics for autoimmune diseases and holds promise for future treatments of fibrotic disorders, vascular diseases, and cancer.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)

Article Peripheral Vascular Disease

Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro

Katsuki Okuyama et al.

Summary: In this study, it was found that cyclic phosphatidic acid (cPA) can enhance the tube formation of HDLECs through the LPA6/ROCK and LPA1/3 signaling pathways, regulating the lymphatic capillary-like morphogenesis and migration adjacent to type I collagen under physiological conditions.

MICROVASCULAR RESEARCH (2022)

Article Chemistry, Multidisciplinary

Synthesis and hydrolytic stability of cyclic phosphatidic acids: implications for synthetic- and proto-cell studies

Veronica Egas Ortuno et al.

Summary: This study presents a robust synthesis method for cyclic phosphatidic acids (cPAs) and investigates their hydrolytic properties, which could advance the understanding of their biological properties and potential use as components of synthetic cells.

CHEMICAL COMMUNICATIONS (2022)

Article Cell Biology

Sphingosine 1-phosphate receptor type 2 positively regulates interleukin (IL)-4/IL-13-induced STAT6 phosphorylation

Yasuo Okamoto et al.

Summary: The study highlights the crucial role of S1P(2) in the activation of STAT6 in macrophages, with its signaling pathway involving the Rho-Rho kinase pathway. Knockout of S1P(2) weakened the IL-4/IL-13-induced phosphorylation of STAT6 and mRNA expression of the M2 marker ARG1.

CELLULAR SIGNALLING (2021)

Article Cell Biology

Adenine nucleotide translocase 2, a putative target protein for 2-carba cyclic phosphatidic acid in microglial cells

Tamotsu Tsukahara et al.

Summary: This study identified the interaction between a metabolically stabilized cPA derivative, 2ccPA, and ANT2 in microglial cells, showing its ability to inhibit apoptosis induced by phenylarsine oxide and improve cell survival.

CELLULAR SIGNALLING (2021)

Article Biochemistry & Molecular Biology

Characterization of recombinant murine GDE4 and GDE7, enzymes producing lysophosphatidic acid and/or cyclic phosphatidic acid

Binderiya Tserendavga et al.

Summary: The study revealed that GDE7 can produce both LPA and cPA, while GDE4 only produces LPA. Both enzymes prefer 1-alkyllysophosphospholipids as substrates.

JOURNAL OF BIOCHEMISTRY (2021)

Article Multidisciplinary Sciences

Highly accurate protein structure prediction with AlphaFold

John Jumper et al.

Summary: Proteins are essential for life, and accurate prediction of their structures is a crucial research problem. Current experimental methods are time-consuming, highlighting the need for accurate computational approaches to address the gap in structural coverage. Despite recent progress, existing methods fall short of atomic accuracy in protein structure prediction.

NATURE (2021)

Article Endocrinology & Metabolism

ATF4-mediated transcriptional regulation protects against -cell loss during endoplasmic reticulum stress in a mouse model

Keisuke Kitakaze et al.

Summary: Transcriptional regulation by ATF4 maintains β-cell identity via ISR modulation, providing a promising target for the treatment of diabetes.

MOLECULAR METABOLISM (2021)

Article Biochemistry & Molecular Biology

Development of a selective fluorescence-based enzyme assay for glycerophosphodiesterase family members GDE4 and GDE7

Keisuke Kitakaze et al.

Summary: The study discovered a fluorescent ATX substrate, FS-3, which could be used to evaluate GDE activity, with the hydrolysis process dependent on Mg2+ and Ca2+. Several ATX inhibitors effectively inhibited GDE4 and GDE7 activities, while the ATX inhibitor S32826 had minimal impact on these activities. These findings provide new insights into the development of selective inhibitors and stimulators for GDEs and a better understanding of their biological roles.

JOURNAL OF LIPID RESEARCH (2021)

Article Multidisciplinary Sciences

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition

Keiko Fukasawa et al.

Summary: Researchers identified the structure and biological activities of 2carbaLPA as a degradation compound of 2ccPA, showing potential for activating certain LPA receptors and inhibiting ATX.

SCIENTIFIC REPORTS (2021)

Review Biochemistry & Molecular Biology

Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies

Luiz Henrique Medeiros Geraldo et al.

Summary: Lysophosphatidic acid (LPA) is a versatile bioactive phospholipid that can signal through specific receptors to have diverse effects in central nervous system development and angiogenesis, as well as acting as a potent mediator in neuropathic pain, neurodegenerative diseases, and cancer progression. Understanding the production and signaling mechanisms of LPA is crucial for comprehending its biological functions in the central nervous system in both health and disease states.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Biochemistry & Molecular Biology

Human GDPD3 overexpression promotes liver steatosis by increasing lysophosphatidic acid production and fatty acid uptake

Chia-Chi C. Key et al.

JOURNAL OF LIPID RESEARCH (2020)

Review Medicine, Research & Experimental

The mechanisms of lysophosphatidylcholine in the development of diseases

Panpan Liu et al.

LIFE SCIENCES (2020)

Article Multidisciplinary Sciences

The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells

Kazuhito Naka et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Emerging roles of lysophospholipids in health and disease

Shu Ting Tan et al.

PROGRESS IN LIPID RESEARCH (2020)

Review Biochemistry & Molecular Biology

Copy Number Variations in Adult-onset Neuropsychiatric Diseases

Alexandra R. Lew et al.

CURRENT GENOMICS (2018)

Review Cell & Tissue Engineering

PPAR-gamma and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively

Yue Li et al.

CURRENT STEM CELL RESEARCH & THERAPY (2018)

Article Biochemistry & Molecular Biology

Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7

Iffat Ara Sonia Rahman et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)

Article Biochemistry & Molecular Biology

Glycerophosphodiesterase GDE4 as a novel lysophospholipase D: a possible involvement in bioactive N-acylethanolamine biosynthesis

Kazuhito Tsuboi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)

Article Biochemistry & Molecular Biology

Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts

Katsura Maeda-Sano et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)

Article Gastroenterology & Hepatology

Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis

Keisuke Kakisaka et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)

Article Medicine, General & Internal

Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis

Akira Tokumura et al.

International Journal of Medical Sciences (2012)

Article Biochemistry & Molecular Biology

Phospholipase D2-Dependent Inhibition of the Nuclear Hormone Receptor PPARγ by Cyclic Phosphatidic Acid

Tamotsu Tsukahara et al.

MOLECULAR CELL (2010)

Article Biochemistry & Molecular Biology

Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ

Tamotsu Tsukahara et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)

Article Biochemistry & Molecular Biology

Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet Activation

Jesica R. Williams et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Biochemistry & Molecular Biology

Cyclic phosphatidic acid - A unique bioactive phospholipid

Yuko Fujiwara

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)

Article Pharmacology & Pharmacy

S32826, A Nanomolar Inhibitor of Autotaxin: Discovery, Synthesis and Applications as a Pharmacological Tool

Gilles Ferry et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Biochemistry & Molecular Biology

firestar -: prediction of functionally important residues using structural templates and alignment reliability

Gonzalo Lopez et al.

NUCLEIC ACIDS RESEARCH (2007)

Article Biochemistry & Molecular Biology

C-terminal loop of Streptomyces phospholipase D has multiple functional roles

Yoshiko Uesugi et al.

PROTEIN SCIENCE (2007)

Article Biochemistry & Molecular Biology

Cyclic phosphatidic acid is produced by autotaxin in blood

Satomi Tsuda et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis

Daniel L. Baker et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators

A Tokumura

JOURNAL OF CELLULAR BIOCHEMISTRY (2004)

Article Multidisciplinary Sciences

GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors

B Zheng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

Localization, topology, and function of the LCB1 subunit of serine palmitolyltransferase in mammalian cells

S Yasuda et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Multidisciplinary Sciences

Identification of an intracellular receptor for lysophosphatidic acid (LPA):: LPA is a transcellular PPARγ agonist

TM McIntyre et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Chemistry, Multidisciplinary

Basic charge clusters and predictions of membrane protein topology

D Juretic et al.

JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2002)

Article Biochemical Research Methods

The HMMTOP transmembrane topology prediction server

GE Tusnády et al.

BIOINFORMATICS (2001)

Article Biochemistry & Molecular Biology

Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes

A Krogh et al.

JOURNAL OF MOLECULAR BIOLOGY (2001)